These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1758440)

  • 41. Interactions of ligands at angiotensin II-receptors and imidazoline receptors.
    Wethmar U; Raasch W; Dendorfer A; Dominiak P
    Jpn J Pharmacol; 2001 Feb; 85(2):167-74. PubMed ID: 11286399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of isolated chromaffin cells to study basic release mechanisms.
    Livett BG; Boksa P; Dean DM; Mizobe F; Lindenbaum MH
    J Auton Nerv Syst; 1983 Jan; 7(1):59-86. PubMed ID: 6188774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
    Chan SL; Atlas D; James RF; Morgan NG
    Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance.
    Ernsberger P; Feinland G; Meeley MP; Reis DJ
    Am J Hypertens; 1990 Feb; 3(2):90-7. PubMed ID: 2155003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla.
    Ernsberger P; Meeley MP; Reis DJ
    Brain Res; 1988 Feb; 441(1-2):309-18. PubMed ID: 2834001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues.
    Escribá PV; Sastre M; Wang H; Regunathan S; Reis DJ; García-Sevilla JA
    Neurosci Lett; 1994 Aug; 178(1):81-4. PubMed ID: 7816347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonadrenergic modulation by clonidine of the cosecretion of catecholamines and enkephalins in adrenal chromaffin cells.
    Nguyen TT; De Léan A
    Can J Physiol Pharmacol; 1987 May; 65(5):823-7. PubMed ID: 2887269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human cerebral imidazoline binding sites. Further biochemical investigations.
    Greney H; Dontenwill M; Bricca G; Belcourt A; Bousquet P
    Ann N Y Acad Sci; 1995 Jul; 763():523-5. PubMed ID: 7677369
    [No Abstract]   [Full Text] [Related]  

  • 49. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling.
    Musgrave IF; Hughes RA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contractile proteins in chromaffin cells.
    Bader MF; Garcia AG; Ciesielski-Treska J; Thierse D; Aunis D
    Prog Brain Res; 1983; 58():21-9. PubMed ID: 6356223
    [No Abstract]   [Full Text] [Related]  

  • 51. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem.
    Bricca G; Dontenwill M; Molines A; Feldman J; Belcourt A; Bousquet P
    Eur J Pharmacol; 1989 Mar; 162(1):1-9. PubMed ID: 2721559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphological characteristics and stimulus-secretion coupling in bovine adcrenal chromaffin cell cultures.
    Trifaró JM; Lee RW
    Neuroscience; 1980; 5(9):1533-46. PubMed ID: 7422128
    [No Abstract]   [Full Text] [Related]  

  • 53. Choline stimulates nicotinic receptors on adrenal medullary chromaffin cells to induce catecholamine secretion.
    Holz RW; Senter RA
    Science; 1981 Oct; 214(4519):466-8. PubMed ID: 7291988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular and physiological properties of clonidine-displacing substance.
    Atlas D
    Ann N Y Acad Sci; 1995 Jul; 763():314-24. PubMed ID: 7677341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity.
    Atlas D
    Biochem Pharmacol; 1991 Jun; 41(11):1541-9. PubMed ID: 1645966
    [No Abstract]   [Full Text] [Related]  

  • 56. Spinal imidazoline receptors do not mediate the antinociceptive action of intrathecal clonidine in the rat.
    Monroe PJ; Smith DL; Smith DJ
    Ann N Y Acad Sci; 1995 Jul; 763():497-500. PubMed ID: 7677364
    [No Abstract]   [Full Text] [Related]  

  • 57. Polyclonal anti-idazoxan antibodies: characterization and purification.
    Fatima B; Hugues G; Giampiero B; Alain B; Pascal B; Dontenwill M
    Eur J Pharmacol; 1993 Jun; 246(1):45-51. PubMed ID: 8354342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonidine-specific antisera recognize an endogenous clonidine-displacing substance in brain.
    Meeley MP; Towle AC; Ernsberger P; Char LK; McCauley PM; Reis DJ
    Hypertension; 1989 Apr; 13(4):341-51. PubMed ID: 2925235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of adrenomedullary catecholamine release by propranolol isomers and clonidine involving mechanisms unrelated to adrenoceptors.
    Orts A; Orellana C; Cantó T; Ceña V; González-García C; García AG
    Br J Pharmacol; 1987 Dec; 92(4):795-801. PubMed ID: 2827826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extraction of active clonidine-displacing substance from bovine lung and comparison with clonidine-displacing substance extracted from other tissues.
    Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Chan SL; Morgan NG; Crosby J
    Eur J Pharmacol; 1999 Aug; 378(2):213-21. PubMed ID: 10478634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.